In accordance with 5 CFR 1320, this collection has been improperly submitted. In Question 15 of the supporting statement, APHIS states, "The number of respondents has decreased from 60 to 55 respondents. This is because APHIS is no longer counting 5 of the respondents twice. There is no change in burden, merely a bookkeeping change to consolidate IC's." OMB notes that the Agency did not enter any change to respondents or burden hours into ROCIS and that the collection is listed as an extension.
Please resubmit this collection for consideration when the supporting statement has been corrected to accurately reflect this request for approval.
Inventory as of this Action
Requested
Previously Approved
03/31/2010
36 Months From Approved
09/30/2010
60
0
60
106
0
106
0
0
0
The purpose of this collection is to collect information that will assist APHIS in its efforts to prevent biological products from harming animals, the public, and the environment.
US Code:
21 USC 117
Name of Law: Animal Industry Act of 1884
The number of respondents has decreased from 60 to 55 respondents. This is because APHIS is no longer counting 5 of the respondents twice. There is no change in burden, merely a bookkeeping change to consolidate IC's.
$5,632
No
No
Uncollected
Uncollected
No
Uncollected
Albert Morgan 301 734-8245
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
71 2009 0318.xls
2009 ss 0318.doc
Viruses, Serums, Toxins, and Analogous Products; Suspension, Revocation, or Termination of Biological Licenses or Permittes, Individuals and Households